Who Buys Mycophenolate from India — 512 Importers Behind a $334.4M Market
India's mycophenolate import market is served by 512 active buyers who collectively imported $334.4M across 2,529 shipments. EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) leads with a 51.1% market share, followed by STRIDES PHARMA INC, and STRIDES PHARMA INC. The top 5 buyers together control 66.8% of total import value, reflecting a concentrated buyer landscape.
Top Mycophenolate Importers — Ranked by Import Value
EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) is the leading mycophenolate importer from India, holding a 51.1% share of the $334.4M market across 2,529 shipments from 512 buyers. The top 5 buyers — EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), STRIDES PHARMA INC, (UNITED STATES), STRIDES PHARMA INC (UNITED STATES), APOTEX PTY LTD (AUSTRALIA), ASCEND LABORATORIES,LLC (UNITED STATES) — collectively control 66.8% of total import value.
Top Mycophenolate Buyers & Importers
Ranked by import value · 512 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCES SERVICES,LLCUNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MG | $170.9M | 5 | 51.1% |
| 2 | STRIDES PHARMA INC,UNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MG | $13.9M | 5 | 4.1% |
| 3 | STRIDES PHARMA INCUNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MG | $13.8M | 5 | 4.1% |
| 4 | APOTEX PTY LTDAUSTRALIA MYCOPHENOLATE SDZ 500MG 50FCT AU MATERIAMYCOPHENOLATE 250MG 50HGC V1 CA MATERIALPHARMACEUTICAL PRODUCTS : PHARMACOR MYCOPHENOLATE 500MGAUS | $12.7M | 5 | 3.8% |
| 5 | ASCEND LABORATORIES,LLCUNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MGMYCOPHENOLATE MOF DEX 500MG TAB 5X10S | $12.1M | 5 | 3.6% |
| 6 | SANDOZ INC. C/O EXEL, INC.UNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MGMYCOPHENOLATE SDZ 500MG 50FCT AU MATERIA | $10.7M | 5 | 3.2% |
| 7 | SANDOZ INC C O EXEL INCUNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MGMYCOPHENOLATE SDZ 500MG 50FCT AU MATERIA | $6.3M | 5 | 1.9% |
| 8 | ASCEND LABORATORIES LLCUNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MGMYCOPHENOLATE MOF DEX 500MG TAB 5X10S | $4.5M | 5 | 1.4% |
| 9 | AVET PHARMACCEUTICALS INC.,UNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MG | $4.1M | 5 | 1.2% |
| 10 | TILLOMED LABORATORIES LTDUNITED KINGDOM MYCOPHENOLATE MOFETIL 500MG- 5X10 TAB (EMYCOPHENOLATE MOFETIL 500MG- 5X10 TAB EMYCOPHENOLATE MOF DEX 500MG TAB 5X10S | $3.9M | 5 | 1.2% |
| 11 | TILLOMED ITALIA SRLITALY MYCOPHENOLATE MOFETIL 500MG- 5X10 TAB (EMYCOPHENOLATE MOFETIL 500MG- 5X10 TAB EMYCOPHENOLATE MOF DEX 500MG TAB 5X10S | $3.5M | 5 | 1.0% |
| 12 | EVERSANA LIFE SCIENCES SERVICES LLCUNITED STATES MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MG | $3.3M | 5 | 1.0% |
| 13 | ASCEND GMBHGERMANY MYCOPHENOLATE MOF 500MG 100FCT BO US MATMYCOPHENOLATE MOFETIL TABLETS USP [500MGMYCOPHENOLATE MOF DEX 500MG TAB 5X10S | $2.5M | 5 | 0.7% |
| 14 | ACCORD FARMACUTICA LTDABRAZIL PHARMA DRUGS AND MEDI MYCOPHENOLATE MOFEMYCOPHENOLATE SDZ 500MG 50FCT AU MATERIAMYCOPHENOLATE MOFETIL 500MG- 5X10 TAB (E | $2.2M | 5 | 0.7% |
| 15 | TILLOMED LABORATORIES LTD.UNITED KINGDOM MYCOPHENOLATE MOFETIL 500MG- 5X10 TAB (EMYCOPHENOLATE MOFETIL 500MG- 5X10 TAB EMYCOPHENOLATE MOF DEX 500MG TAB 5X10S | $2.1M | 5 | 0.6% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Mycophenolate — and from which countries?
Flow of Mycophenolate exports from India: each country's share and the named importers behind the numbers
Mycophenolate — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $256.2M through 596 shipments. This represents a market share of 76.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCES SERVICES,LLC - $170.9M (66.7% of country's total business)
• STRIDES PHARMA INC, - $13.9M (5.4% of country's total business)
• STRIDES PHARMA INC - $13.8M (5.4% of country's total business)
• ASCEND LABORATORIES,LLC - $12.1M (4.7% of country's total business)
• SANDOZ INC. C/O EXEL, INC. - $10.7M (4.2% of country's total business)
• Rest of United States's importers - $34.8M (13.6% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $429.8K, indicating premium pricing strategy compared to the market average of $132.2K.
United States is a key market for Mycophenolate imports, representing 76.6% of total trade value.
2Australia
Australia emerges as the second largest importing country, achieving a total trade value of $20.5M through 25 shipments. This represents a market share of 6.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• APOTEX PTY LTD - $12.7M (62.1% of country's total business)
• SANDOZ PTY LTD - $1.8M (8.6% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $819.2K, indicating premium pricing strategy compared to the market average of $132.2K.
Australia is a key market for Mycophenolate imports, representing 6.1% of total trade value.
3United Kingdom
United Kingdom emerges as the third largest importing country, achieving a total trade value of $13.0M through 109 shipments. This represents a market share of 3.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• TILLOMED LABORATORIES LTD - $3.9M (29.8% of country's total business)
• TILLOMED LABORATORIES LTD. - $2.1M (16.0% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $119.6K, indicating competitive pricing strategy compared to the market average of $132.2K.
United Kingdom is a key market for Mycophenolate imports, representing 3.9% of total trade value.
4Italy
Italy emerges as the fourth largest importing country, achieving a total trade value of $4.4M through 51 shipments. This represents a market share of 1.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Italy has a diverse importer base, with their top importers including:
• TILLOMED ITALIA SRL - $3.5M (79.0% of country's total business)
Key Insight: Italy demonstrates strong market positioning with an average shipment value of $86.4K, indicating competitive pricing strategy compared to the market average of $132.2K.
Italy is a key market for Mycophenolate imports, representing 1.3% of total trade value.
5Brazil
Brazil emerges as the fifth largest importing country, achieving a total trade value of $4.1M through 19 shipments. This represents a market share of 1.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• ACCORD FARMACUTICA LTDA - $2.2M (53.1% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $218.3K, indicating premium pricing strategy compared to the market average of $132.2K.
Brazil is a key market for Mycophenolate imports, representing 1.2% of total trade value.
Buyer Segment Analysis
TransData Nexus Mycophenolate buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Mycophenolate exports from India amounted to $334.4 million across 2,529 shipments, involving 167 exporters and 512 buyers spanning 100 importing countries. The repeat buyer rate stands at 53.7%, suggesting a stable demand base.
Distributors: Entities such as EVERSANA LIFE SCIENCES SERVICES, LLC, which accounted for $170.93 million in imports to the United States, fall into this category. Distributors typically purchase large volumes to supply various healthcare providers, including hospitals and pharmacies. Their buying behavior is characterized by bulk orders and long-term contracts to ensure consistent supply chains.
Contract Manufacturers: Companies like STRIDES PHARMA INC., importing $13.86 million worth of Mycophenolate to the United States, are indicative of contract manufacturing operations. These firms procure active pharmaceutical ingredients (APIs) or finished products to produce generic formulations under their brand names. Their purchasing patterns often involve substantial quantities aligned with production schedules and market demand forecasts.
Government Procurement: While specific entities such as UNICEF or national health services are not listed among the top buyers in our data, government procurement agencies in various countries engage in tender-based purchasing to supply public healthcare facilities. These agencies prioritize cost-effectiveness and compliance with regulatory standards, often resulting in large, periodic orders.
Country-Specific Import Regulations
TransData Nexus Mycophenolate buyer market intelligence
1Country-Specific Import Regulations
United States:
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Mycophenolate is approved by the FDA. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs or a New Drug Application (NDA) for new formulations. Additionally, facilities involved in manufacturing, processing, or packaging must be registered with the FDA.
3. Estimated Timeline for Registration: The FDA review process for an ANDA typically takes 10 months, though this can vary based on the completeness of the application and any required amendments.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.
Australia:
1. Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Mycophenolate must be listed in the Australian Register of Therapeutic Goods (ARTG). Importers are required to submit a dossier demonstrating the product's quality, safety, and efficacy.
3. Estimated Timeline for Registration: The TGA's evaluation process can take approximately 12 months, depending on the complexity of the application and the need for additional information.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties in Australia.
United Kingdom:
1. Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
2. Import Registration Process: Importers must obtain a Marketing Authorization (MA) from the MHRA, which requires submission of comprehensive data on the product's quality, safety, and efficacy.
3. Estimated Timeline for Registration: The MHRA aims to process applications within 210 days; however, this timeline can extend if additional information is requested.
4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally subject to a 0% import duty in the UK.
Italy:
1. Regulatory Authority: Italian Medicines Agency (AIFA).
2. Import Registration Process: AIFA requires a Marketing Authorization, necessitating submission of a dossier that includes clinical data and manufacturing details.
3. Estimated Timeline for Registration: The evaluation process typically takes 210 days, though it may be extended if further information is needed.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are usually exempt from import duties in Italy.
Brazil:
1. Regulatory Authority: National Health Surveillance Agency (ANVISA).
2. Import Registration Process: Importers must obtain a Sanitary Authorization from ANVISA, which involves submitting technical dossiers demonstrating the product's safety, efficacy, and quality.
3. Estimated Timeline for Registration: The registration process can take up to 12 months, depending on the complexity of the application and any additional requirements.
4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are subject to an import duty of 8% in Brazil.
Demand Drivers & Market Opportunity
TransData Nexus Mycophenolate buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Mycophenolate in importing countries is primarily driven by its critical role in preventing organ transplant rejection and treating certain autoimmune diseases. The inclusion of Mycophenolate on the World Health Organization's Model List of Essential Medicines underscores its importance in global health. This designation encourages countries to prioritize its availability within their healthcare systems.
Government healthcare programs and the expansion of universal health coverage further bolster demand. Many countries incorporate Mycophenolate into their national formularies, facilitating procurement through tender-based purchasing mechanisms. The presence of 512 buyers across 100 countries, as per our data, reflects a widespread and sustained demand, presenting significant market opportunities for suppliers.
Common Questions — Mycophenolate Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest mycophenolate buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) leads with $170.9M in imports and a 51.1% market share — the highest of any single mycophenolate importer. STRIDES PHARMA INC, (UNITED STATES) and STRIDES PHARMA INC (UNITED STATES) are the next largest buyers.
QHow many companies buy mycophenolate from India?
There are 512 active mycophenolate buyers importing from India, with a combined market of $334.4M across 2,529 shipments to 100 countries. The top 5 buyers hold 66.8% of total import value, while the remaining 507 buyers handle the other 33.2%.
QWhich countries import the most mycophenolate from India?
The top importing countries for mycophenolate from India are United States (76.6%), Australia (6.1%), United Kingdom (3.9%), Italy (1.3%), Brazil (1.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of mycophenolate, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for mycophenolate from India?
The average import transaction value for mycophenolate from India is $132.2K, with an average unit price of $15.03 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Mycophenolate buyer market intelligence
1Buyer Segment Analysis
Our data indicates that Mycophenolate exports from India amounted to $334.4 million across 2,529 shipments, involving 167 exporters and 512 buyers spanning 100 importing countries. The repeat buyer rate stands at 53.7%, suggesting a stable demand base.
Distributors: Entities such as EVERSANA LIFE SCIENCES SERVICES, LLC, which accounted for $170.93 million in imports to the United States, fall into this category. Distributors typically purchase large volumes to supply various healthcare providers, including hospitals and pharmacies. Their buying behavior is characterized by bulk orders and long-term contracts to ensure consistent supply chains.
Contract Manufacturers: Companies like STRIDES PHARMA INC., importing $13.86 million worth of Mycophenolate to the United States, are indicative of contract manufacturing operations. These firms procure active pharmaceutical ingredients (APIs) or finished products to produce generic formulations under their brand names. Their purchasing patterns often involve substantial quantities aligned with production schedules and market demand forecasts.
Government Procurement: While specific entities such as UNICEF or national health services are not listed among the top buyers in our data, government procurement agencies in various countries engage in tender-based purchasing to supply public healthcare facilities. These agencies prioritize cost-effectiveness and compliance with regulatory standards, often resulting in large, periodic orders.
Country-Specific Import Regulations
TransData Nexus Mycophenolate buyer market intelligence
1Country-Specific Import Regulations
United States:
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Mycophenolate is approved by the FDA. This involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs or a New Drug Application (NDA) for new formulations. Additionally, facilities involved in manufacturing, processing, or packaging must be registered with the FDA.
3. Estimated Timeline for Registration: The FDA review process for an ANDA typically takes 10 months, though this can vary based on the completeness of the application and any required amendments.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS Code 30049099 are generally duty-free in the United States.
Australia:
1. Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Mycophenolate must be listed in the Australian Register of Therapeutic Goods (ARTG). Importers are required to submit a dossier demonstrating the product's quality, safety, and efficacy.
3. Estimated Timeline for Registration: The TGA's evaluation process can take approximately 12 months, depending on the complexity of the application and the need for additional information.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties in Australia.
United Kingdom:
1. Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
2. Import Registration Process: Importers must obtain a Marketing Authorization (MA) from the MHRA, which requires submission of comprehensive data on the product's quality, safety, and efficacy.
3. Estimated Timeline for Registration: The MHRA aims to process applications within 210 days; however, this timeline can extend if additional information is requested.
4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally subject to a 0% import duty in the UK.
Italy:
1. Regulatory Authority: Italian Medicines Agency (AIFA).
2. Import Registration Process: AIFA requires a Marketing Authorization, necessitating submission of a dossier that includes clinical data and manufacturing details.
3. Estimated Timeline for Registration: The evaluation process typically takes 210 days, though it may be extended if further information is needed.
4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are usually exempt from import duties in Italy.
Brazil:
1. Regulatory Authority: National Health Surveillance Agency (ANVISA).
2. Import Registration Process: Importers must obtain a Sanitary Authorization from ANVISA, which involves submitting technical dossiers demonstrating the product's safety, efficacy, and quality.
3. Estimated Timeline for Registration: The registration process can take up to 12 months, depending on the complexity of the application and any additional requirements.
4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are subject to an import duty of 8% in Brazil.
Demand Drivers & Market Opportunity
TransData Nexus Mycophenolate buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Mycophenolate in importing countries is primarily driven by its critical role in preventing organ transplant rejection and treating certain autoimmune diseases. The inclusion of Mycophenolate on the World Health Organization's Model List of Essential Medicines underscores its importance in global health. This designation encourages countries to prioritize its availability within their healthcare systems.
Government healthcare programs and the expansion of universal health coverage further bolster demand. Many countries incorporate Mycophenolate into their national formularies, facilitating procurement through tender-based purchasing mechanisms. The presence of 512 buyers across 100 countries, as per our data, reflects a widespread and sustained demand, presenting significant market opportunities for suppliers.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 512 global importers of Mycophenolate identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 2,529 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 100 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,529 Verified Shipments
512 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists